Xib13 peptide program (Xiber Science)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameXib13 peptide program (Xiber Science)
Drug Alias NameXib13-01Xib13-03Xib13-02Xib13-04Xib-05
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsBurnsMultiple Organ FailureAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXIBER Science GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXIBER Science GmbH
Active IndicationsN/A
Inactive IndicationsBurnsMultiple Organ FailureAcute Lung Injury

Other Information

ATC CodeN/A
Related LinksN/A